Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000769993-25-000072
Filing Date
2025-02-10
Accepted
2025-02-10 17:30:28
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 9696
2 POA13G-20863785_20250128.txt EX-99 5139
  Complete submission text file 0000769993-25-000072.txt   16815
Mailing Address 200 WEST STREET NEW YORK NY 10282
Business Address 200 WEST STREET NEW YORK NY 10282 212-902-1000
GOLDMAN SACHS GROUP INC (Filed by) CIK: 0000886982 (see all company filings)

EIN.: 134019460 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A
SIC: 6211 Security Brokers, Dealers & Flotation Companies
(CF Office: 02 Finance)

Mailing Address 222 BERKELEY STREET 12TH FLOOR BOSTON MA 02116
Business Address 222 BERKELEY STREET 12TH FLOOR BOSTON MA 02116 857-264-4280
RHYTHM PHARMACEUTICALS, INC. (Subject) CIK: 0001649904 (see all company filings)

EIN.: 462159271 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-90134 | Film No.: 25606818
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)